Articles tagged AI health

Six independent proteomic clocks measured a 3 to 6 year drop in biological age in patients treated with rentosertib, a molecule designed by AI.

Claude designed protein binders that hit 14 of 15 targets, landing a 26.8 percent success rate where the field usually sits at 10 to 15 percent.

Anthropic launches its own drug discovery programs targeting diseases big pharma calls unprofitable. Our AI health verdict.